4//SEC Filing
Karkus Ted William 4
Accession 0001493152-22-015068
CIK 0000868278other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:20 PM ET
Size
9.5 KB
Accession
0001493152-22-015068
Insider Transaction Report
Form 4
Karkus Ted William
10% Owner
Transactions
- Exercise/Conversion
Common Stock, par value $0.005
2022-05-23$2.00/sh+450,000$900,000→ 2,783,471 total - Exercise/Conversion
Option (right to buy)
2022-05-23−450,000→ 0 totalExercise: $2.00Exp: 2024-04-27→ Common Stock (450,000 underlying) - Tax Payment
Common Stock, par value $0.005
2022-05-23$8.47/sh−278,257$2,356,837→ 2,505,214 total
Holdings
- 100,000(indirect: By Son)
Common Stock, par value $0.005
Footnotes (2)
- [F1]On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes.
- [F2]The option vested in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeother
Related Parties
1- filerCIK 0001457896
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 5:20 PM ET
- Size
- 9.5 KB